Life Sciences Industry News
-
PhotoPharmics Stay-At-Home Trial for People with Parkinson’s
This week, PhotoPharmics announced a collaboration with the Center for Health + Technology (CHeT) at the University of…
-
Jim Greenwood: Thank You and Looking Forward
A letter from departing BIO president Jim Greenwood originally sent May 27, 2020 After more than fifteen years…
-
Alucent Biomedical Announces First Patient Enrolled in Phase 1 Natural Vascular Scaffolding Clinical Trial
Multicenter ACTIVATE I Study to Enroll up to 15 Patients in the U.S. SALT LAKE CITY – May…
-
FDA Clears Park City-Based Transit Scientific’s XO Cross Microcatheter Platform
Park City, Utah USA, May 12, 2020 /PRNewswire/ — Transit Scientific announced the FDA cleared the XO Cross…
-
Impactful Innovation Exchange: Calling all Solutions!
How can we advance the utilization of innovations in healthcare? By lending them extra visibility to key stakeholders! Join the Impactful Innovation…
-
Silver lining: opportunities can arise from the corona crisis
Author: Anja Petschauer Co-authors: Anna Derschang, Melitta Gilllespie gwSaar has been a member of BioUtah and a trusted partner…
-
PhotoPharmics Gets FDA Breakthrough Status for Parkinson’s PhotoTherapy
PhotoPharmics, a pioneer in specialized phototherapy, announced on April 29, that it has received FDA Breakthrough device designation…
-
FDA Grants Breakthrough Designation for Non-Invasive Phototherapy Device in Parkinson’s Disease
PhotoPharmics achieves priority designation for innovative PD therapy April 29, 2020, Salt Lake City, UT— PhotoPharmics, a pioneer…
-
FDA Clears New Disposable Fog-Free Articulating 5mm Laparoscope
SALT LAKE CITY, April 14, 2020 /PRNewswire/ — Xenocor, Inc. announced the FDA cleared the new Xenocor Disposable 5mm Articulating Laparoscope…
-
Romney Announces Resource to Keep Utahns Informed on Coronavirus
WASHINGTON—U.S. Senator Mitt Romney (R-UT) today announced the launch of a new webpage designed to keep Utahns informed…
-
Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide
Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million…
-
Rep. Curtis Sends Letter to Treasury Department Advocating for Small Business Relief
FOR IMMEDIATE RELEASE: March 20, 2020 Media Contact: Ally Riding (202) 226-7721 Washington, DC— Today, Representative John…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
